Latus Bio
3 known investors
Latus develops gene therapies based on novel AAV capsid variants matched to optimized routes of administration, aiming to target specific cell types and tissues to lower dose requirements, toxicity, and manufacturing costs. It focuses on treating monogenic diseases affecting the central nervous system and peripheral tissues using computational methods and unbiased capsid screening.
AI & Machine LearningBiotechDeep Tech
Investors · 3
Frequently asked questions
- What does Latus Bio do?
- Latus develops gene therapies based on novel AAV capsid variants matched to optimized routes of administration, aiming to target specific cell types and tissues to lower dose requirements, toxicity, and manufacturing costs. It focuses on treating monogenic diseases affecting the central nervous system and peripheral tissues using computational methods and unbiased capsid screening.
- Who are Latus Bio's investors?
- Latus Bio's investors include 8VC, DCVC (Data Collective), Modi Ventures.